MAI Capital Management Sells 534 Shares of Amgen, Inc.
MAI Capital Management lessened its holdings in Amgen, Inc. by 0.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 72,445 shares of the medical research company's stock after selling 534 shares during the quarter.
from Biotech News
0 Comments